Washington: Observing the evolution of a particular type of antibody in an infected HIV-1 patient has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.The kind of antibody studied is called a broadly cross-reactive neutralizing antibody, and details of its generation could provide a blueprint for effective vaccination, the study`s researchers said.
Kargil Vijay Diwas: Arun Jaitley pays homage to martyrs
Clashes in Saharanpur, curfew clamped
Four men from Mumbai join ISIS in Iraq
Tension high in Moradabad, Laxmikant Bajpai, Rita Bahuguna arrested